The effects of nizatidine on transient lower esophageal sphincter relaxations (TLESRs) and acid reflux in healthy subjects

Journal of Smooth Muscle Research

Volumn 47, Issue 6, 2012, Pages 157-166

  Iwakiri, Katsuhiko ^a   Kawami, Noriyuki ^a   Sano, Hirohito ^a   Tanaka, Yuriko ^a   Umezawa, Mariko ^a   Futagami, Seiji ^a   Hoshihara, Yoshio ^a,b   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Ministry of Economy Trade and Industry   (Japan)

Author keywords

Acid reflux; Esophageal acid exposure; Nizatidine; Transient lower esophageal sphincter relaxation

Indexed keywords

HISTAMINE AGONIST; NIZATIDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESOPHAGEAL PH MONITORING; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMAN; MUSCLE RELAXATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SMOOTH MUSCLE;

ESOPHAGEAL PH MONITORING; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HISTAMINE AGONISTS; HUMANS; MUSCLE RELAXATION; MUSCLE, SMOOTH; NIZATIDINE;

EID: 84859247100     PISSN: 09168737     EISSN: None     Source Type: Journal    
DOI: 10.1540/jsmr.47.157     Document Type: Article

References (27)

1. Adachi, K., Ono, M., Kawamura, A., Yuki, M., Fujishiro, H. and Kinoshita, Y. (2002). Nizatidine and cisapride enhance salivary secretion in humans. Aliment. Pharmacol. Ther. 16: 297-301.
2. Barbara, L., Corinaldesi, R., Dobrilla, G., De, Pretis, G., Porro, G.B., Prada, A., Carratù, R., Paoluzi, P., Mazzacca, G., Sabbatini, F., Scuro, LA., Gavalliti, GC., Verme, G. and Pera, A. (1983). Ranitidine vs cimetidine: short-term treatment of gastric ulcer. Hepatogastroenterol. 30: 151-153.
3. Boeckxstaens, G.E., Hirsch, D.P., Fakhry, N., Holloway, R.H., D'Amato, M. and Tytgat, G.N. (1998). Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxations triggered by gastric distension. Am. J. Gastroenterol. 93: 1823-1828.
4. Boulant, J., Mathieu, S., D'Amato, M., Abergel, A., Dapoigny, M. and Bommelaer, G. (1997). Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans. Gut 40: 575-581.
5. Clavé, P., González, A., Moreno, A., López, R., Farré, A., Cussó, X., D'Amato, M., Azpiroz, F. and Lluis, F. (1998). Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors. Gastroenterol. 115: 597-604.
6. Hamamoto, N., Hashimoto, T., Adachi, K., Hirakawa, K., Ishihara, S., Inoue, H., Taniura, H., Niigaki, M., Sato, S., Kushiyama, Y., Suetsugu, H., Miyake, T. and Kinoshita, Y. (2005). Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis. J. Gatroenterol. Hepatol. 20: 281-286.
7. Harasawa, S. and Miwa, T. (1993). The effect of nizatidine on gastric emptying and plasma gastrin concentration in patients with peptic ulcer. Jpn. Pharmacol. Ther. 21: 965-972 (in Japanese with English abstract).
8. Hayashi, Y., Iwakiri, K., Kotoyori, M. and Sakamoto, C. (2008). Mechanisms of acid gastroesophageal reflux in the Japanese population. Dig. Dis. Sci. 53: 1-6.
9. Hirsch, D.P., Tytgat, G.N.J. and Boeckxstaens, G.E.E. (2002). Transient lower oesophageal sphincter relaxations -a pharmacological target for gastro-oesophageal reflux disease? Aliment. Pharmacol. Ther. 16: 17-26.
10. Holloway, R.H, Kocyan, F.P. and Dent, J. (1991). Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesohageal reflux. Dig. Dis. Sci. 36: 1034-1039.
11. Holloway, R.H., Penagini, R. and Ireland, A.C. (1995). Criteria for objective definition of transient lower esophageal sphincter relaxation. Am. J. Physiol. 268: G128-G133.
12. Inoue, M. (1988). Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan. Drugs 35 (Suppl. 3): 114-119.
13. Iwakiri, K., Hayashi, Y., Kotoyori, M., Tanaka, Y., Kawakami, A., Sakamoto, C. and Holloway, R.H. (2005). Transient lower esophageal sphincter relaxations (TLESRs) are major mechanism of gastroesophageal reflux but are not the cause of reflux disease. Dig. Dis. Sci. 50: 1072-1077.
14. Iwakiri, K., Kawami, N., Sano, H., Tnanaka, Y., Umezawa, M., Kotoyori, M., Hoshihara. Y. and Sakamoto, C. (2009). Mechanisms of excessive esophageal acid exposure in patients with reflux esophagitis. Dig. Dis. Sci. 54: 1686-1692.
15. Judmaier, G. (1988). A comparison of roxatidine acetate and ranitidine in gastric ulcer healing. Drugs 35 (Suppl. 3): 120-126.
16. Kawahara, H., Dent, J. and Davidson, G. (1997). Mechanisms responsible for gastroesophageal reflux in children. Gastroenterol. 113: 399-408.
17. Lidums, I., Lehmann. A., Checklin, H., Dent, J. and Holloway, R.H. (2000). Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterol. 118: 7-13.
18. Mittal, R.K., Chiareli, C., Liu, J., Holloway, R.H. and Dixon, W.Jr. (1997). Atropine inhibits gastric distension and pharyngeal receptor mediated lower esophageal sphincter relaxation. Gut 41: 285-290.
19. Naccaratto, R., Cremer, M., Dammann, H.G., Keohane, P.P., Mulder, H., Sarles, H., Simon, B. and Members of the European nizatidine gastric ulcer study group. (1987). Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial. Scand. J. Gastroenterol. 22 (Suppl 136): 71-78.
20. Nakano, S., Takayama, T., Ohki, H., Toyoda, H., Ebata, M., Machida, K., Kiriyama, S., Suga, T., Osada, T., Sugiyama, K., Kumada, T., Takeda, I., Okabe, H., Sugiyama, T. and Sakai, Y. (1984). Clinical evaluation of E3810 (proton pump inhibitor) on reflux esophagitis. Modern. Physcian. 14: 116-123 (in Japanese).
21. Penagini, R. and Bianchi, P.A. (1997). Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation. Gastroenterol. 113: 409-414.
22. Penagini, R., Schoeman, M.N., Dent, J., Tippet, M.D. and Holloway, R.H. (1996). Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis. Neurogastroenterol. Motil. 8: 131-141.
23. Sekiguchi, T., Takasu, Y., Miwa, T., Kogure, M., Nishioka, T., Toki, M., Tsuchiya, H., Kubota, Y., Umeda, N., Mori, K., Hoshino, E., Mori, H., Shibata, H., Okabe, H., Saigenji, K., Muto, Y., Takai, T., Ohama, Y. and Ikezono, I. (1983). Clinical evaluation of famotidine on reflux esophagitis. New Remedies & Therapy 20: 2476-2485 (in Japanese).
24. Sekiguchi, T., Tsuneoka, K., Kobayashi, M., Kogure, T., Fukutomi, H., Nakahara, A., Kobayashi, S., Nishioka, T., Matsuzaki, T., Matsuo, Y., Iwasaki, A., Nomura, T., Matsuzaka, S., Noguchi, M., Fukuchi, S., Hayakawa, K., Hoshihara, Y., Miwa, T., Harasawa, S., Muto, N. and Nomura, K. (1989). Clinical evaluation of nizatidine on reflux esophagitis. Jpn. Pharmacol. Ther. 17 (Suppl. 2): 457-468 (in Japanese).
25. Shiomi, S., Ishizu, H., Kawamura, E., Iwata, Y., Tamori, A., Habu, D., Takeda, T., Nishiguchi, S. and Kawabe, J. (2001). Effect of nizatidine on gastric emptying in patients with cirrhosis of the liver. Jpn. Pharmacol. Ther. 29: 761-765.
26. Vela, M.F., Tutuian, R., Katz, P.O. and Castell, D.O. (2003). Baclofen decreases acid and non-acid postprandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment. Pharmacol. Ther. 17: 243-251.
27. Zhang, Q., Lehmann, A., Rigda, R., Dent, J. and Holloway, R.H. (2002). Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 50: 19-24.